Clinical trial
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
NCT03500731
Study timeline
Study start (actual)2018-04-19Date precision: day
Registry last updated2026-01-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Idiopathic Pulmonary Fibrosisunresolved
Emphysema or COPDunresolved
Interventions
RituximabDRUG · verified · RxNorm: rituximab
AlemtuzumabDRUG · verified · RxNorm: alemtuzumab
FludarabineDRUG · verified · RxNorm: fludarabine
ThiotepaDRUG · verified · RxNorm: thiotepa
G-CSFDRUG
HydroxyureaDRUG · verified · RxNorm: hydroxyurea
Sponsors & collaborators
Paul Szabolcslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03500731 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.